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Influenza epidemics occur once a year during the win-
ter in temperate areas. Little is known about the similarities
between epidemics at different locations. We have ana-
lyzed pneumonia and influenza deaths from 1972 to 1997
in the United States, France, and Australia to examine the
correlation over space and time between the three coun-
tries. We found a high correlation in both areas between
France and the United States (correlation in impact,
Spearman’s ρ= 0.76, p < 0.001, and test for synchrony in
timing of epidemics, p < 0.001). We did not find a similar
correlation between the United States and Australia or
between France and Australia, when considering a system-
atic half-year lead or delay of influenza epidemics in
Australia as compared with those in the United States or
France. These results support a high correlation at the
hemisphere level and suggest that the global interhemi-
spheric circulation of epidemics follows an irregular path-
way with recurrent changes in the leading hemisphere. 
I
nfluenza epidemics occur each year during the winter in
temperate areas of the Northern and the Southern
Hemispheres and result in substantial disease, death, and
expense. The disease is responsible for 50 million illnesses
and up to 47,200 deaths in the United States each year
(1–3), with similar figures in Europe (4–6). In the last cen-
tury, three global epidemics, also called pandemics,
occurred in 1918-19, 1957-58, and 1968-69, and recent
reports estimate that the 1918-19 influenza pandemic alone
may have caused as many as 50 million deaths (7).
Changing strains of the virus are responsible for these epi-
demics, but little is known about what triggers the epidem-
ic in a particular location (2,8), and how epidemics
observed at different locations may be linked (9–12).
Travel has been thought to be a possible cause after math-
ematical models based on population movements success-
fully explained the 1968-69 pandemic (10) and represented
the paths of the epidemic within a country (9,11,12). While
the cause of the geographic spread of influenza is still
debated, the reasons for its seasonality are even more
unclear. Although markedly seasonal, the exact timing
of the winter epidemics varies from year to year.
Furthermore, the interannual impact of influenza epi-
demics varies substantially (1,3,4). 
Documenting patterns in the space and time dynamics
of influenza epidemics is the first step in understanding the
underlying mechanisms driving epidemic fluctuations
(13). Correlations over time and space have been estimat-
ed for several animal and insect populations (14–16) and
diseases such as measles (17–19) but not for influenza,
despite the increasing availability of time series with the
recent development of surveillance networks (3,20–28).
We provide data and a statistical analysis for the correla-
tions over time and space for influenza-related deaths in
the United States, France, and Australia during a 26-year
period which spans 1972–1997. Our goal was to determine
whether influenza epidemics are correlated in impact and
synchronized in time 1) at the hemispheric level and 2) at
the interhemispheric level with a systematic half-year lead
of one hemisphere to the other. 
Datasets and Models 
Datasets
In each country, the weekly number of deaths from
pneumonia and influenza from 1972 to 1997 were comput-
ed from death certificates collected by national agencies
for vital statistics (United States, National Center for
Health Statistics; Australia, Australian Bureau for
Statistics; France, Institut National de la Santé et de la
Recherche Médicale, Service Commun 8). We used codes
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select deaths due to pneumonia and influenza. Annual pop-
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the study period. The population sizes in 1997 in the
United States, France, and Australia were 272.7 million,
58.6 million, and 18.9 million, respectively. 
Data Analysis 
From the pneumonia and influenza death series, we
investigated two aspects of influenza epidemics: the corre-
lation in impact as measured by seasonal excess death rates
and the synchrony in timing of the epidemic peaks. 
Definition of Epidemic and Excess Deaths
Influenza epidemic activity is typically observed during
November–March in the United States and France and
June–September in Australia (8). We conducted analyses
by using the influenza year, which runs from the first week
of August to the last week of July of the next year in the
United States and France and contains one annual epidem-
ic. We considered the regular calendar year as the influen-
za year in Australia. From the national weekly pneumonia
and influenza death time series, we defined the epidemic
periods by a similar procedure to that described by Serfling
and used by the Centers for Disease Control and
Prevention (CDC) (29,30). In summary, we excluded 25%
of the weeks in which the observed death rates were the
largest to exclude epidemic periods. We then fit a seasonal
regression model to the truncated series to estimate the
expected baseline number of deaths in the absence of epi-
demic activity. A nonepidemic threshold was defined by
the upper limit of the 95% confidence interval derived
from the seasonal regression model. Only influenza activ-
ities that remained above the threshold for >2 consecutive
weeks were included in the analysis. For each influenza
year, we measured the excess deaths by subtracting the
expected baseline deaths, calculated from the seasonal
regression model, from the observed deaths. 
Estimating Correlation in Excess Deaths from
Influenza Epidemics 
We calculated pair-wise Spearman correlation coeffi-
cients of the excess deaths estimated for each of the 26
influenza years in the study period for the three countries.
For France and the United States, epidemics were paired
for contemporaneous influenza years. To test for correla-
tion between the United States and Australia or between
France and Australia, we investigated two pairing scenar-
ios: 1) influenza epidemics in Australia were systemati-
cally 6 months in advance of those of the United States
and France for the 26 years considered, and 2) influenza
epidemics in Australia were systematically 6 months
behind. 
Estimating Synchrony in Timing of 
Peaks of Influenza Epidemics 
For each influenza year and each country, we defined
the week of the year when the peak of the epidemic
occurred as the week where the maximal number of pneu-
monia and influenza deaths was observed. Then, we deter-
mined the distribution of the time lags between the weeks
of the peak in France and in the United States in contem-
poraneous influenza years, with negative values of the
time lag indicating that the epidemic in France preceded
that in the United States. The same distribution was calcu-
lated for Australia and the United States and for Australia
and France, with the two scenarios detailed in the previous
section for pairing. We expected the time lags of the peaks
in the United States and France to be distributed around
zero if the assumption of synchronism of the peaks held
true, with a small variance indicating high synchrony. 
To test whether the reported distribution of the time
lags was indicative of synchrony, we simulated the distri-
bution of these lags when there was no particular synchro-
nization mechanism between these two countries except
for the seasonality of the disease. We randomly permuted
the week when the pneumonia and influenza death time
series peaked in the United States for the 26 influenza
years and computed the distribution of the lags with the
original series from France. A p value for the existence of
synchrony in the peaks was derived from this randomiza-
tion procedure. 
With regards to Australia, because of the change of
hemisphere, we expected the week of the peak to lag by 6
months on average with that of the United States or France,
regardless of the pairing scenario. Here again, the small
variance of distribution of the time lags would indicate
synchronism. For both pairing scenarios, we performed a
randomization procedure similar to that described for com-
paring France and the United States to derive a p value for
synchrony in the peaks.
Results
Figure 1 depicts the raw time series of weekly number
of deaths from pneumonia and influenza in the United
States, France, and Australia, normalized by population
size. The series show a typical seasonal pattern, with large
interannual variability in the amplitude of epidemics in all
three countries. The pneumonia and influenza death series
for Australia appears less smooth than for the United States
or France, probably because of noise effects caused by the
smaller population size of Australia, representing 7% of
the population size of the United States and 32% of that of
France. 
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For the 26 influenza years (1972–1997), we estimated a
median of 26 per million population pneumonia and
influenza excess deaths in the United States (range 0-63),
39 per million pneumonia and influenza excess deaths in
France (range 0-183), and 13 per million pneumonia and
influenza excess deaths in Australia (range 0-75). The rates
of excess deaths were different in the three countries
(Kruskal-Wallis test, p = 0.02). The Table gives the
detailed annual estimates of the number of excess deaths
for each influenza year. Two of 26 influenza years in the
United States did not result in substantial excess pneumo-
nia and influenza deaths, 4 in France, and 3 in Australia.
The duration of the epidemic periods was similar in France
and in the United States, with an average duration of 11.8
weeks in the United States (standard deviation (SD) = 0.8)
and 11.4 weeks in France (SD = 0.8, p = 0.80, Wilcoxon
rank test). The epidemic periods in Australia were shorter
than those in the United States and in France, with an aver-
age duration of 9.6 weeks (SD = 1.0; Kruskal-Wallis test,
p < 0.001). 
Correlation in Excess Deaths 
The correlation coefficient for excess deaths in the
United States and France in contemporaneous influenza
years was high (Spearman’s ρ = 0.76, N = 26, p < 0.001;
Figure 2A). On the contrary, excess deaths in Australia
were not correlated with excess deaths in France or the
United States in the scenario in which Australia was sys-
tematically 6 months in advance (Spearman’s ρ = 0.14 for
Australia and the United States, p = 0.50 and ρ = 0.37 for
Australia and France, p = 0.06; Figure 2B and C) or in the
scenario in which Australia was systematically 6 months
behind (Spearman’s ρ = 0.15 for Australia and the United
States, p = 0.47 and Spearman’s ρ = 0.17 for Australia and
France, p = 0.37). 
Synchrony in Timing of Peaks 
In France and in the United States, in the 26 influenza
years, the median time lag between the weeks when the
peak occurred was half a week (N = 26, range –8 through
6) reflecting a high level of synchrony (Figure 3A). The
peak occurred earlier in the United States in 11 of the 26
epidemic seasons, earlier in France in 13 epidemic sea-
sons, and on the same week for both countries in 2 epidem-
ic seasons. Influenza epidemics did not peak earlier in
France more often than in the United States, or vice versa
(chi square, p = 0.66). Of the 100,000 randomizations we
performed by permuting the week of the peak, 2 gave a
variance for the time lags lower than that reported for the
original data (Figure 4A; p < 0.001). Therefore, these
results show synchronism in the times of peaks between
France and the United States. 
In the scenario in which the influenza season in
Australia was systematically 6 months in advance of that
in the Northern Hemisphere, the median time lag between
the peaks in Australia and in the United States was 27
weeks (range 14-39) and 26 weeks between those in
Australia and in France (range 15-41; Figure 3B and C). In
the scenario in which the influenza season in Australia was
systematically 6 months behind that in the Northern
Hemisphere, these lags were 25.5 weeks (range 13-36) and
24.5 weeks (range 13-34), respectively. The simulated dis-
tributions obtained from the 100,000 permutations of the
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Figure 1. Weekly number of influenza and pneu-
monia deaths per 10 million population from
January 1972 to December 1997 in the United
States, France, and Australia (black line). The red
line represents the epidemic threshold defined by
a seasonal regression.week were not different from the observed distributions (in
the scenario in which the influenza season in Australia was
6 months behind, p = 0.70 and p = 0.79 for the United
States and France, respectively [Figure 4B and C] and in
the scenario in which it was 6 months in advance, p = 0.13
and p = 0.12). For these two pairing scenarios, no syn-
chrony in the peaks was evident. 
Discussion
The results of this study favor a high level of correla-
tion in amplitude and synchrony in the timing of influenza
epidemics in France and the United States. No correlation
or synchrony was found between Australia and the United
States, or between Australia and France in the two scenar-
ios in which Australia systematically led or lagged behind
the global interhemispheric circulation of epidemics by 6
months. 
The level of correlation in amplitude evidenced here
depends on the statistical method used for estimating sea-
sonal excess deaths. We have used a similar procedure to
that described by Serfling and used by the CDC for esti-
mating excess deaths (3,29). In our study, periods of
increased influenza activity were excluded from the base-
line model by discarding upper marginal values that were
above a somewhat arbitrary cutoff (25th percentile of the
distribution), and we found a high correlation between
excess deaths in the United States and France (Spearman’s
correlation coefficient ρ = 0.76). The correlation remained
stable with a lower cutoff set at 10%: in this analysis the
correlation coefficient was also 0.76. Moreover, our excess
death estimates are well in line with those published for the
United States (3,31,32) and for France by using a different
statistical approach (4). For the United States and France,
the correlation coefficients between our estimates of pneu-
monia and influenza excess deaths and the most recently
published estimates were 0.87 and 0.94, respectively, with
similar orders of magnitude (3,4). No comparable esti-
mates were available for Australia. Pneumonia and
influenza death series have been used traditionally since
the work of William Farr in the late 1840s to quantify the
effect of influenza epidemics in terms of death (33)
because severe complications are triggered by influenza
infection and result in death, in particular bacterial pneu-
monia (34). The use of pneumonia death series might
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Table. Number of pneumonia and influenza excess deaths and duration in weeks (wk, in parentheses) of influenza epidemics for each 
influenza year in the United States, France, and Australia, 1972–1997 
Influenza season  
(Northern Hemisphere) 
a  U.S. excess deaths (wk)
b  France excess deaths (wk)
c 
Influenza season  
(Southern Hemisphere)
 d 
Australian excess deaths 
(wk)
e 
1971-72  8,100 (9)  4,200 (13)  1972  200 (11) 
1972-73  11,000 (13)  9,500 (13)  1973  250 (10) 
1973-74  4,100 (15)  0 (0)  1974  150 (6) 
1974-75  9,000 (13)  7,000 (16)  1975  900 (14) 
1975-76  13,600 (13)  4,800 (12)  1976  0 (0) 
1976-77  600 (3)  1,400 (9)  1977  1,000 (16) 
1977-78  10,000 (13)  2,500 (8)  1978  200 (8) 
1978-79  0 (0)  300 (4)  1979  100 (7) 
1979-80  4,200 (9)  0 (0)  1980  250 (13) 
1980-81  8,600 (10)  3,100 (11)  1981  200 (9) 
1981-82  0 (0)  0 (0)  1982  0 (0) 
1982-83  1,400 (5)  1,800 (10)  1983  700 (15) 
1983-84  700 (4)  0 (0)  1984  250 (12) 
1984-85  7,000 (11)  2,300 (15)  1985  150 (8) 
1985-86  6,000 (13)  4,700 (18)  1986  650 (15) 
1986-87  2,000 (7)  900 (9)  1987  0 (0) 
1987-88  8,700 (18)  700 (8)  1988  100 (7) 
1988-89  7,000 (16)  1,000 (9)  1989  200 (9) 
1989-90  10,400 (14)  4,300 (11)  1990  750 (17) 
1990-91  3,300 (12)  1,000 (10)  1991  100 (6) 
1991-92  6,800 (10)  2,900 (16)  1992  50 (3) 
1992-93  6,300 (16)  2,100 (16)  1993  300 (14) 
1993-94  9,800 (11)  2,600 (11)  1994  50 (3) 
1994-95  5,300 (15)  900 (10)  1995  300 (10) 
1995-96  6,300 (16)  2,500 (17)  1996  100 (5) 
1996-97  11,400 (18)  4,500 (13)  1997  250 (10) 
aExcess deaths reported from August of a given year to July of the next year during an influenza epidemic (e.g., for row labeled 1971-72, excess deaths occurring from 
August 1971 to July 1972). 
bPopulation, 272.7 million. 
cPopulation, 58.6 million. 
dExcess deaths reported from January to December of a given year during an influenza epidemic (e.g., for row labeled 1972, excess deaths occurring from January 1972 to 
December 1972). 
ePopulation, 18.9 million. introduce additional background noise in estimating
excess deaths caused by influenza, especially because of
the high level of activity in the summer and the upward
trend observed since the early 1980s (6). We performed a
sensitivity analysis by restricting our calculations of
excess deaths to deaths coded as influenza only and
retrieved a similar correlation between the United States
and France (Spearman’s ρ = 0.75). However, we do not
capture the total impact of influenza by analyzing only
pneumonia and influenza death, which accounts for only
part of the overall deaths from influenza (4,34). Therefore,
we probably cannot rely strictly on our absolute estimates
of excess deaths to study the overall impact of influenza
epidemics on death. However, pneumonia and influenza
deaths series provide a robust and unbiased indicator of the
severity of influenza epidemics for between-country com-
parisons. In addition, with an indicator as simple and crude
as the raw pneumonia and influenza deaths observed dur-
ing the week of the peak, the correlation remains of the
same order (Spearman’s ρ = 0.73). 
Demography may contribute to the lack of correlation
and synchrony between Australia and the United States or
between Australia and France. While the age structures of
the populations in the three countries are similar, the pop-
ulation sizes are different. Discrepancies in the levels of
vaccination might also play a role. However, the number
of doses of influenza vaccine distributed was similar in
France and the United States from 1980 until the early
1990s but doubled in recent years in the United States
(35). The level of vaccination in Australia was about half
of that of France and the United States from 1980 until
1990 and became similar to that of France in recent years
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Figure 3. Synchrony in the timing of the peaks of influenza epidemics for 26 influenza years (1972–1997). Correlation between the week
of year of the epidemic peak A, in the United States (x axis) and in France (y axis). B, in the United States (x axis) and in Australia (y
axis). C, in France (x axis) and in Australia (y axis). Panels B) and C) illustrate the scenario in which the influenza season in Australia is
systematically 6 months before that of the United States or France. Similar results are obtained for the reverse scenario. 
Figure 2. Correlation in the impact of influenza epidemics for 26 influenza years (1972–1997), measured by the annual number of pneu-
monia and influenza excess deaths. A, excess deaths per million in France (y axis) and the United States (x axis) in contemporaneous
winters: Spearman correlation coefficient = 0.76 (p < 0.001). B, excess deaths per million in Australia (y axis) and the United States (x
axis), considering the scenario in which the influenza season in Australia is systematically 6 months before that of the United States:
Spearman correlation coefficient = 0.14 (p = 0.50). C, excess deaths per million in Australia (y axis) and France (x axis), considering the
scenario where the influenza season in Australia is systematically 6 months before that of France: Spearman correlation coefficient =
0.37 (p = 0.06). We obtained similar results as in B and C, when we considered a reverse scenario in which the influenza season in
Australia was systematically lagging 6 months behind that in the United States or France. (35). Therefore, no obvious link existed between trends in
vaccination and our results.
An important limitation in the analysis of correlation
and synchrony between countries in different hemispheres
lies in the arbitrary choice for pairing epidemics. We inves-
tigated two extreme scenarios in which influenza epi-
demics in Australia were systematically 6 months ahead of
those in France or the United States or systematically 6
months behind. We found no correlation or synchrony in
either one. We cannot rule out a more complex interhemi-
spheric pathway with recurrent changes in the leading
hemisphere. We searched for an optimal theoretical pair-
ing, allowing each epidemic in Australia in our simulations
to pair with either the preceding or following epidemic in
the United States (or France) to maximize the correlation
in excess death. For optimal pairing, the correlation coef-
ficients obtained were in the same order of magnitude as
those observed between France and the United States
(Spearman’s ρ = 0.66 for the United States and Australia
and Spearman’s ρ = 0.71 for Australia and France). 
Few reports document the circulation of influenza virus
on a worldwide scale. Hope-Simpson studies of death, dis-
ease, and virologic datasets suggest that the circulation of
influenza strains (and the epidemics they cause) may fol-
low a given pathway during several years (e.g., Southern
to Northern Hemisphere) and subsequently shift to the
other pathway (e.g., Northern to Southern Hemisphere)
(36). This finding agrees with the absence of significant
time and space correlations found in this work between
countries in different hemispheres when epidemics were
paired 6 months ahead or behind. If this absence of corre-
lation between the two hemispheres, observed in death
records limited to an interpandemic period and a limited
set of countries, held true in the case of a pandemic, infor-
mation on previous routes of transmission derived from
historical epidemics (10,37) could prove of little use for
planning the route of future epidemics or pandemics on a
worldwide scale. 
Our study nevertheless strongly suggests that influen-
za epidemics are correlated in amplitude and synchro-
nized in timing in the Northern Hemisphere, and collec-
tion and analysis of additional data is underway in other
countries of Europe and North America. Prevaccination
measles epidemics in different locales of the United States
and the United Kingdom were also highly correlated in
time and space, a situation that evolved to the observed
absence of correlation in the last 2 decades after the level
of vaccination increased from 50% to 90% (17,19). This
lack of correlation is reportedly promoting persistence of
the disease (19). Space and time correlations of influenza
epidemics may follow the same pattern as vaccine cover-
age increases. How the very high rate of antigenic evolu-
tion of influenza virus, a feature not found in measles,
could impact on this change requires further study, all the
more as antigenic variations explain partly the impact of
the disease (3,19,38–40). The current plan to control
influenza advocated by the World Health Organization
promotes vaccine use and, in case of emergence of a pan-
demic virus, extensive use of antiviral drugs and vaccine,
assuming that the vaccine could be produced in a timely
fashion (41). The impact of an expected loss of correla-
tions in influenza epidemics resulting from in creased
vaccine use should be further investigated, especially by
mathematical modeling.
In conclusion, two factors have been reported to drive
the space and time correlations of epidemics: population
movements and environmental issues, such as climate or
weather conditions (14–16). Population movements are
assumed to play a key role, though not quantified, in the
global spread of influenza epidemics (8,10), but the role of
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Figure 4. Synchrony in the timing of the peaks of influenza epidemics for 26 influenza years (1972–1997). Distribution of the time lags
between the epidemic peaks in weeks (wk, main plot). The red bars represent the observed lags, and the dashed line represents the dis-
tribution of lags obtained by permutations. (inset plot) Distribution of the standard deviation of permuted lags under the assumption of no
synchrony. Red arrow indicates the standard deviation in the observed data. A, United States and France, B) United States and Australia,
C, France and Australia. Panels B and C illustrate the scenario in which the influenza season in Australia is systematically 6 months
before that of the United States or France. Similar results are obtained for the reverse scenario.environmental factors and virus circulation between the
Southern and Northern Hemispheres (42–44) remains to
be clarified. Large-scale molecular epidemiologic studies
of influenza viruses, sampled from locations in different
hemispheres, could assist in investigating the circulation
pathways of the disease (44). Such large-scale studies
seem feasible in light of the recent plan for a global sen-
tinel laboratory that could centralize genotype and archive
samples collected worldwide (45). 
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